News Focus
News Focus
icon url

Tails

09/27/14 6:25 PM

#71168 RE: CallMeCrazy #71164

An excellent presentation/comparison and forecast.

CTIX will most likely be on that very path shortly.
Leo and Menon chose (perhaps had no alternative) to go the reverse merger route in order to maintain total control until value had been created through trials. They funded it and their choice is precisely what has allowed us to participate at such an early stage. Thank you Leo and De Menon.
Now, with the science showing positive results via trials we are about to transform from a pos pinky to a serious "player".
The analyst coverage will come eventually. The media coverage, the interviews, the whole ball of wax.

Our job is to sit tight. And I continue to recommend the 57 thread Mike Johnson Polygrass Calf Rope to secure your a$$ in the saddle.

Go CTIX!
icon url

streamingeagle88

09/27/14 6:32 PM

#71170 RE: CallMeCrazy #71164

Great DD and perspective.

This to me is the most compelling piece of research indicating why the stock should be bought at these prices. For certain partnering is in the near future and all three drugs have wide spread application.

Thanks Crazy. I feel as though I've been awakened from a long slumber.
icon url

Phoenix300

09/27/14 6:35 PM

#71171 RE: CallMeCrazy #71164

CMC some very powerful points were made in that post.

Looking forward to Monday already.
icon url

JUST 10-11-12

09/27/14 6:37 PM

#71172 RE: CallMeCrazy #71164

not going to call you crazy!
icon url

TheMonolith

09/28/14 1:13 AM

#71196 RE: CallMeCrazy #71164

Awesome post!
icon url

John B

09/28/14 5:44 AM

#71200 RE: CallMeCrazy #71164

Excellent post Crazy, on the positive effect that partnering can have on Share Price and valuation. Thanks!
icon url

Whoops

09/28/14 12:53 PM

#71225 RE: CallMeCrazy #71164

CMC great post! Clovis Oncology Inc. is a company that Cellceutix has mentioned before and another head scratcher. The cred. will come when the company is vetted by big pharma in a partnership...big pharma will leave no stone unturned. Cred. will also come with uplisting with all of its oversight rules. People don't talk about it much but our company has a cred. problem (its the only thing that can explain the pps) that will soon be resolved. IMO